Description

Scabies Treatment Market Outline

 

Scabies is a contagious skin infection caused by Sarcoptes scabiei. Pimple like rashes and severe itchiness are the symptoms associated with scabies. The mode of transmission of scabies is skin-to-skin contact. The common site of infestation include armpits, around fingernails, inner elbow, in between fingers, and soles of feet among others. Scabies can be treated by antibiotics, antihistamines, and steroid creams. Improper hygienic conditions and environmental factors are the key factor to increase the number of person affected to scabies. Moreover, low cost of drugs, increase in R&D for the innovation of newer drugs, rapid escalation of global population with poor hygienic, and increase in healthcare expenditure are anticipated to fuel the scabies treatment market. Moreover, homecare remedies for the scabies treatment and limited number of advanced therapeutics are expected to restrain the growth of scabies treatment market.

 

Scabies Treatment Market

 

Market Scope: Scabies Treatment Market

The market is segmented on the basis of drug type, route of administration, and distribution channel

Based on the drug type

  • Sulphur Ointment
  • Benzyl Benzoate Lotion
  • Lindane Lotion
  • Crotamiton Cream
  • Permethrin Cream
  • Others

Based on the route of administration

  • Oral
  • Topical

Based on the distribution channel,

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Regional Analysis

Geographically, global scabies treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America scabies treatment market has a lucrative growth attributed to increase in the R&D for innovation of newer drugs, rise in healthcare expenditure, and grow in preference for health concerns are expected to boost the market. Europe scabies treatment market is grow at healthy CAGR due to increased investments  in R&D for the innovation of newer drugs, better availability of products, and rise in disposable income. Asia pacific scabies treatment market is expected increase revenue due to increase in population with unhygienic condition, expansion of business by market players, and adoption of newer drugs over the forecast years.

 

Competition Assessment

  • Merck & Co. Inc. (U.S.)
  • Renaissance Pharma, Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • GlaxoSmithKline plc (U.K.)
  • Unichem Laboratories Ltd. (India)
  • Zydus Cadila (India)
  • Prestium Pharma, Inc. (U.S.)

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (The USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2015-2019) and forecast (2020-2026)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0


Location

GEOGRAPHY

PBI Location Map

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX